Get the Stockscreener App
70.44
6.52%
4.31
After Hours:
70.82
0.38
+0.54%
Grail Inc stock is traded at $70.44, with a volume of 604.63K.
It is up +6.52% in the last 24 hours and up +85.17% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
See More
Previous Close:
$66.13
Open:
$68.35
24h Volume:
604.63K
Relative Volume:
0.66
Market Cap:
$2.54B
Revenue:
$117.67M
Net Income/Loss:
$-1.88B
P/E Ratio:
-1.1636
EPS:
-60.5369
Net Cash Flow:
$-621.36M
1W Performance:
+14.17%
1M Performance:
+85.17%
6M Performance:
+202.84%
1Y Performance:
+386.13%
1-Day Range:
$65.27
$70.84
1-Week Range:
$60.24
$75.53
52-Week Range:
$12.76
$75.53
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
(833) 694-2553
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
70.44 | 2.38B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
524.58 | 198.17B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
205.14 | 144.97B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
633.32 | 49.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.23 | 38.73B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
203.77 | 33.69B | 15.70B | 1.24B | 2.01B | 6.9036 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Canaccord Genuity | Buy |
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
Grail Inc Stock (GRAL) Latest News
Will GRAIL LLC stock deliver better than expected guidance2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com
Why GRAIL Inc. (NL0) stock could rally strongly2025 Big Picture & Breakout Confirmation Trade Signals - newser.com
President Joshua Ofman Sold A Bunch Of Shares In GRAIL - simplywall.st
GRAIL (NASDAQ:GRAL) Hits New 52-Week HighHere's Why - MarketBeat
The holy grail of modern marketing - Fast Company
11,400 Shares in GRAIL, Inc. $GRAL Purchased by Trifecta Capital Advisors LLC - MarketBeat
CRCM LP Reduces Stake in GRAIL Inc.: A Strategic Portfolio Adjustment - GuruFocus
GRAIL (NASDAQ:GRAL) President Sells $5,086,562.50 in Stock - MarketBeat
GRAIL (NASDAQ:GRAL) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Recent Developments Impacting GRAL - timothysykes.com
GRAIL (NASDAQ:GRAL) Trading Up 7.6%Here's Why - MarketBeat
Do Insider Sales at GRAIL (GRAL) Hint at Shifting Management Confidence Amid Revenue Growth? - simplywall.st
GRAIL (GRAL): Evaluating Valuation After 20% Revenue Growth and Modest Share Price Gains - Yahoo Finance
Slow Capital Inc. Raises Stock Holdings in GRAIL, Inc. $GRAL - MarketBeat
GRAIL (NASDAQ:GRAL) Trading Down 4% Following Insider Selling - MarketBeat
Liquid Biopsy for Early Cancer Detection and Monitoring Market Report 2025-2033, with Profiles of GRAIL, AnchorDx, Burning Rock Biotech, Genecast, Guardant Health, Elypta, Freenome, and Oncimmune - GlobeNewswire
Why GRAIL Inc. (NL0) stock stays on top picksTrade Volume Summary & High Accuracy Trade Signal Alerts - newser.com
Insider Sell: Joshua Ofman Sells 9,692 Shares of GRAIL Inc (GRAL) - GuruFocus
Biotech Breakthrough: GRAIL (GRAL) Stock Surges on New Cancer-Detection Data! - ts2.tech
Grail price target raised to $75 from $43 at Canaccord - TipRanks
How GRAIL Inc. (NL0) stock trades under stagflationEarnings Overview Report & Fast Gaining Stock Strategy Reports - newser.com
Grail Inc stock hits all-time high of 64.0 USD By Investing.com - Investing.com Nigeria
Grail Inc stock hits all-time high of 64.0 USD - Investing.com India
GRAIL (NASDAQ:GRAL) Reaches New 1-Year HighHere's What Happened - MarketBeat
GRAIL Inc Signs New Headquarters Lease Agreement - MSN
Making Sense of the Numbers: Interpreting Multi-Cancer Early Detection Test Performance - MarketScreener
GRAIL Inc. (GRAL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Grail: A Speculative Buy (NASDAQ:GRAL) - Seeking Alpha
Wealth Enhancement Advisory Services LLC Acquires 6,032 Shares of GRAIL, Inc. $GRAL - MarketBeat
Will GRAL’s Latest Spike Sustain? - timothysykes.com
GRAIL (NASDAQ:GRAL) Stock Price Up 7.2%Still a Buy? - MarketBeat
Why Is GRAIL Stock Rising? - StocksToTrade
Illumina, Grail Beat Investor Suit Over Doomed Acquisition (2) - Bloomberg Law News
What drives GRAIL Inc NL0 stock priceCovered Call Writing & Hidden Gems with Outstanding Profit Margins - earlytimes.in
The European Commission prohibits and plans to unwind Illumina's acquisition of GRAIL - Norton Rose Fulbright
GRAIL, Inc. (GRAL): A Bull Case Theory - MSN
What drives GRAIL LLC stock priceInsider Buying Signals & Compound Your Gains With Quality Stocks - Early Times
Illumina And Grail Nix Investor Suit Over Failed Deal, For Now - Law360
This Cancer Detection Pioneer Is Worth a Look - Yahoo Finance
Is GRAIL LLC stock attractive after correctionSwing Trade & High Conviction Investment Ideas - newser.com
Will Rising Galleri Adoption Drive Growth For GRAIL Stock? - RTTNews
Dakota Wealth Management Makes New Investment in GRAIL, Inc. $GRAL - MarketBeat
GRAIL to Showcase New Data for Galleri Multicancer Early Detection Test at Key Fall Meetings - Patient Care Online
GRAIL to Present New Galleri® Data From More Than 32,000 Partici - GuruFocus
GRAIL to present first PATHFINDER 2 results at ESMO Congress By Investing.com - Investing.com South Africa
GRAIL to present first PATHFINDER 2 results at ESMO Congress - Investing.com
GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC - MarketScreener
32,000-Patient Study: GRAIL's Blood Test Doubles Early Cancer Detection Rate in Landmark Research - Stock Titan
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Grail Inc Stock (GRAL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ofman Joshua J. | President |
Oct 02 '25 |
Sale |
64.00 |
9,692 |
620,312 |
478,182 |
1.61%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):